Software - Infrastructure
Compare Stocks
5 / 10Stock Comparison
DOX vs WIT vs INFY vs CTSH vs ACN
Revenue, margins, valuation, and 5-year total return — side by side.
Information Technology Services
Information Technology Services
Information Technology Services
Information Technology Services
DOX vs WIT vs INFY vs CTSH vs ACN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Software - Infrastructure | Information Technology Services | Information Technology Services | Information Technology Services | Information Technology Services |
| Market Cap | $7.06B | $20.74B | $51.04B | $24.61B | $112.19B |
| Revenue (TTM) | $4.58B | $900.02B | $19.85B | $21.41B | $72.11B |
| Net Income (TTM) | $572M | $135.47B | $3.21B | $2.23B | $7.68B |
| Gross Margin | 37.6% | 30.1% | 30.0% | 32.1% | 32.0% |
| Operating Margin | 17.7% | 16.8% | 20.3% | 15.7% | 14.8% |
| Forward P/E | 8.5x | 0.2x | 16.8x | 9.1x | 13.0x |
| Total Debt | $826M | $192.03B | $962M | $1.57B | $8.18B |
| Cash & Equiv. | $325M | $121.97B | $2.86B | $1.90B | $11.48B |
DOX vs WIT vs INFY vs CTSH vs ACN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Amdocs Limited (DOX) | 100 | 102.4 | +2.4% |
| Wipro Limited (WIT) | 100 | 117.5 | +17.5% |
| Infosys Limited (INFY) | 100 | 141.0 | +41.0% |
| Cognizant Technolog… (CTSH) | 100 | 97.5 | -2.5% |
| Accenture plc (ACN) | 100 | 89.5 | -10.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: DOX vs WIT vs INFY vs CTSH vs ACN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
DOX is the #2 pick in this set and the best alternative if income & stability is your priority.
- Dividend streak 12 yrs, beta 0.58, yield 3.1%
- Beta 0.58 vs ACN's 0.85, lower leverage
- -24.7% vs ACN's -39.1%
WIT ranks third and is worth considering specifically for sleep-well-at-night and valuation efficiency.
- Lower volatility, beta 0.64, Low D/E 23.1%, current ratio 2.72x
- PEG 0.02 vs INFY's 2.52
- Beta 0.64, yield 3.2%, current ratio 2.72x
- Lower P/E (0.2x vs 13.0x), PEG 0.02 vs 1.44
INFY carries the broadest edge in this set and is the clearest fit for long-term compounding.
- 73.6% 10Y total return vs DOX's 36.5%
- 16.2% margin vs CTSH's 10.4%
- 4.6% yield, 4-year raise streak, vs ACN's 3.2%
- 18.6% ROA vs DOX's 9.0%, ROIC 31.8% vs 15.6%
Among these 5 stocks, CTSH doesn't own a clear edge in any measured category.
ACN is the clearest fit if your priority is growth exposure.
- Rev growth 7.4%, EPS growth 6.2%, 3Y rev CAGR 4.2%
- 7.4% revenue growth vs DOX's -9.4%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 7.4% revenue growth vs DOX's -9.4% | |
| Value | Lower P/E (0.2x vs 13.0x), PEG 0.02 vs 1.44 | |
| Quality / Margins | 16.2% margin vs CTSH's 10.4% | |
| Stability / Safety | Beta 0.58 vs ACN's 0.85, lower leverage | |
| Dividends | 4.6% yield, 4-year raise streak, vs ACN's 3.2% | |
| Momentum (1Y) | -24.7% vs ACN's -39.1% | |
| Efficiency (ROA) | 18.6% ROA vs DOX's 9.0%, ROIC 31.8% vs 15.6% |
DOX vs WIT vs INFY vs CTSH vs ACN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
DOX vs WIT vs INFY vs CTSH vs ACN — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
INFY leads in 2 of 6 categories
DOX leads 2 • CTSH leads 1 • WIT leads 0 • ACN leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
INFY leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
WIT is the larger business by revenue, generating $900.0B annually — 196.6x DOX's $4.6B. INFY is the more profitable business, keeping 16.2% of every revenue dollar as net income compared to CTSH's 10.4%. On growth, ACN holds the edge at +8.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $4.6B | $900.0B | $19.8B | $21.4B | $72.1B |
| EBITDAEarnings before interest/tax | $1.0B | $178.7B | $4.3B | $3.9B | $12.1B |
| Net IncomeAfter-tax profit | $572M | $135.5B | $3.2B | $2.2B | $7.7B |
| Free Cash FlowCash after capex | $755M | $145.9B | $3.8B | $2.5B | $12.5B |
| Gross MarginGross profit ÷ Revenue | +37.6% | +30.1% | +30.0% | +32.1% | +32.0% |
| Operating MarginEBIT ÷ Revenue | +17.7% | +16.8% | +20.3% | +15.7% | +14.8% |
| Net MarginNet income ÷ Revenue | +12.5% | +15.1% | +16.2% | +10.4% | +10.7% |
| FCF MarginFCF ÷ Revenue | +16.5% | +16.2% | +19.2% | +11.5% | +17.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | +4.1% | +3.5% | +3.2% | +5.8% | +8.3% |
| EPS Growth (YoY)Latest quarter vs prior year | +9.0% | +1.3% | -5.3% | +3.7% | +3.9% |
Valuation Metrics
CTSH leads this category, winning 6 of 7 comparable metrics.
Valuation Metrics
At 11.4x trailing earnings, CTSH trades at a 31% valuation discount to INFY's 16.6x P/E. Adjusting for growth (PEG ratio), CTSH offers better value at 0.94x vs INFY's 2.48x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $7.1B | $20.7B | $51.0B | $24.6B | $112.2B |
| Enterprise ValueMkt cap + debt − cash | $7.6B | $21.5B | $49.1B | $24.3B | $108.9B |
| Trailing P/EPrice ÷ TTM EPS | 12.90x | 14.99x | 16.56x | 11.42x | 14.83x |
| Forward P/EPrice ÷ next-FY EPS est. | 8.55x | 0.15x | 16.84x | 9.07x | 13.00x |
| PEG RatioP/E ÷ EPS growth rate | 2.03x | 1.75x | 2.48x | 0.94x | 1.64x |
| EV / EBITDAEnterprise value multiple | 7.43x | 11.18x | 10.59x | 5.95x | 8.60x |
| Price / SalesMarket cap ÷ Revenue | 1.56x | 2.18x | 2.65x | 1.17x | 1.61x |
| Price / BookPrice ÷ Book value/share | 2.10x | 2.37x | 4.64x | 1.67x | 3.53x |
| Price / FCFMarket cap ÷ FCF | 10.95x | 12.75x | 12.49x | 9.48x | 10.32x |
Profitability & Efficiency
INFY leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
INFY delivers a 29.6% return on equity — every $100 of shareholder capital generates $30 in annual profit, vs $15 for CTSH. INFY carries lower financial leverage with a 0.09x debt-to-equity ratio, signaling a more conservative balance sheet compared to ACN's 0.25x. On the Piotroski fundamental quality scale (0–9), WIT scores 7/9 vs ACN's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +16.5% | +15.7% | +29.6% | +14.8% | +23.9% |
| ROA (TTM)Return on assets | +9.0% | +10.3% | +18.6% | +10.9% | +11.8% |
| ROICReturn on invested capital | +15.6% | +13.4% | +31.8% | +18.7% | +26.8% |
| ROCEReturn on capital employed | +16.8% | +16.2% | +33.5% | +21.1% | +24.9% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 7 | 5 | 6 | 5 |
| Debt / EquityFinancial leverage | 0.24x | 0.23x | 0.09x | 0.10x | 0.25x |
| Net DebtTotal debt minus cash | $501M | $70.1B | -$1.9B | -$326M | -$3.3B |
| Cash & Equiv.Liquid assets | $325M | $122.0B | $2.9B | $1.9B | $11.5B |
| Total DebtShort + long-term debt | $826M | $192.0B | $962M | $1.6B | $8.2B |
| Interest CoverageEBIT ÷ Interest expense | 23.45x | 12.90x | 90.32x | 107.78x | 40.67x |
Total Returns (Dividends Reinvested)
DOX leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in DOX five years ago would be worth $9,650 today (with dividends reinvested), compared to $5,881 for WIT. Over the past 12 months, DOX leads with a -24.7% total return vs ACN's -39.1%. The 3-year compound annual growth rate (CAGR) favors WIT at -1.9% vs ACN's -9.3% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -18.0% | -29.9% | -30.7% | -35.7% | -29.4% |
| 1-Year ReturnPast 12 months | -24.7% | -27.5% | -26.0% | -31.7% | -39.1% |
| 3-Year ReturnCumulative with dividends | -21.3% | -5.7% | -7.5% | -9.8% | -25.5% |
| 5-Year ReturnCumulative with dividends | -3.5% | -41.2% | -19.0% | -22.9% | -29.5% |
| 10-Year ReturnCumulative with dividends | +36.5% | +0.3% | +73.6% | +0.0% | +89.9% |
| CAGR (3Y)Annualised 3-year return | -7.7% | -1.9% | -2.6% | -3.4% | -9.3% |
Risk & Volatility
DOX leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
DOX is the less volatile stock with a 0.58 beta — it tends to amplify market swings less than ACN's 0.85 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. DOX currently trades 68.3% from its 52-week high vs INFY's 41.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.53x | 0.64x | 0.86x | 0.71x | 0.80x |
| 52-Week HighHighest price in past year | $95.41 | $3.13 | $30.00 | $87.03 | $325.71 |
| 52-Week LowLowest price in past year | $62.75 | $1.97 | $12.16 | $50.81 | $173.52 |
| % of 52W HighCurrent price vs 52-week peak | +68.3% | +63.3% | +41.9% | +59.7% | +55.3% |
| RSI (14)Momentum oscillator 0–100 | 41.9 | 35.7 | 41.0 | 23.6 | 33.5 |
| Avg Volume (50D)Average daily shares traded | 980K | 13.1M | 16.2M | 5.9M | 5.7M |
Analyst Outlook
Evenly matched — INFY and ACN each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: DOX as "Buy", WIT as "Hold", INFY as "Hold", CTSH as "Hold", ACN as "Buy". Consensus price targets imply 271.2% upside for WIT (target: $7) vs 34.3% for INFY (target: $17). For income investors, INFY offers the higher dividend yield at 4.62% vs CTSH's 2.44%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Hold | Hold | Buy |
| Price TargetConsensus 12-month target | $90.00 | $7.35 | $16.90 | $81.75 | $299.92 |
| # AnalystsCovering analysts | 11 | 21 | 40 | 51 | 53 |
| Dividend YieldAnnual dividend ÷ price | +3.1% | +3.2% | +4.6% | +2.4% | +3.2% |
| Dividend StreakConsecutive years of raises | 12 | 1 | 4 | 9 | 14 |
| Dividend / ShareAnnual DPS | $2.01 | $5.99 | $0.58 | $1.27 | $5.85 |
| Buyback YieldShare repurchases ÷ mkt cap | +7.8% | 0.0% | 0.0% | +5.6% | +4.1% |
INFY leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). DOX leads in 2 (Total Returns, Risk & Volatility). 1 tied.
DOX vs WIT vs INFY vs CTSH vs ACN: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is DOX or WIT or INFY or CTSH or ACN a better buy right now?
For growth investors, Accenture plc (ACN) is the stronger pick with 7.
4% revenue growth year-over-year, versus -9. 4% for Amdocs Limited (DOX). Cognizant Technology Solutions Corporation (CTSH) offers the better valuation at 11. 4x trailing P/E (9. 1x forward), making it the more compelling value choice. Analysts rate Amdocs Limited (DOX) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — DOX or WIT or INFY or CTSH or ACN?
On trailing P/E, Cognizant Technology Solutions Corporation (CTSH) is the cheapest at 11.
4x versus Infosys Limited at 16. 6x. On forward P/E, Wipro Limited is actually cheaper at 0. 2x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Wipro Limited wins at 0. 02x versus Infosys Limited's 2. 52x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — DOX or WIT or INFY or CTSH or ACN?
Over the past 5 years, Amdocs Limited (DOX) delivered a total return of -3.
5%, compared to -41. 2% for Wipro Limited (WIT). Over 10 years, the gap is even starker: ACN returned +90. 1% versus WIT's -1. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — DOX or WIT or INFY or CTSH or ACN?
By beta (market sensitivity over 5 years), Amdocs Limited (DOX) is the lower-risk stock at 0.
53β versus Infosys Limited's 0. 86β — meaning INFY is approximately 61% more volatile than DOX relative to the S&P 500. On balance sheet safety, Infosys Limited (INFY) carries a lower debt/equity ratio of 9% versus 25% for Accenture plc — giving it more financial flexibility in a downturn.
05Which is growing faster — DOX or WIT or INFY or CTSH or ACN?
By revenue growth (latest reported year), Accenture plc (ACN) is pulling ahead at 7.
4% versus -9. 4% for Amdocs Limited (DOX). On earnings-per-share growth, the picture is similar: Wipro Limited grew EPS 20. 4% year-over-year, compared to 0. 0% for Infosys Limited. Over a 3-year CAGR, INFY leads at 5. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — DOX or WIT or INFY or CTSH or ACN?
Infosys Limited (INFY) is the more profitable company, earning 16.
4% net margin versus 10. 6% for Cognizant Technology Solutions Corporation — meaning it keeps 16. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: INFY leads at 21. 1% versus 14. 7% for ACN. At the gross margin level — before operating expenses — DOX leads at 36. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is DOX or WIT or INFY or CTSH or ACN more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Wipro Limited (WIT) is the more undervalued stock at a PEG of 0. 02x versus Infosys Limited's 2. 52x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Wipro Limited (WIT) trades at 0. 2x forward P/E versus 16. 8x for Infosys Limited — 16. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for WIT: 271. 2% to $7. 35.
08Which pays a better dividend — DOX or WIT or INFY or CTSH or ACN?
All stocks in this comparison pay dividends.
Infosys Limited (INFY) offers the highest yield at 4. 6%, versus 2. 4% for Cognizant Technology Solutions Corporation (CTSH).
09Is DOX or WIT or INFY or CTSH or ACN better for a retirement portfolio?
For long-horizon retirement investors, Amdocs Limited (DOX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
53), 3. 1% yield). Both have compounded well over 10 years (DOX: +34. 1%, INFY: +76. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between DOX and WIT and INFY and CTSH and ACN?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.